<DOC>
	<DOC>NCT00233740</DOC>
	<brief_summary>The main objective of this study is to monitor the safety and effectiveness of the OptEase™ Permanent Vena Cava (IVC) Filter</brief_summary>
	<brief_title>Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF)</brief_title>
	<detailed_description />
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<criteria>· Pulmonary thromboembolism when anticoagulants are contraindicated. Failure of anticoagulant therapy in thromboembolic diseases. Emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced. Chronic, recurrent pulmonary embolism where anticoagulant therapy has failed or is contraindicated. · Patients with risk of septic embolism. Patients with uncontrolled infectious disease. Patients with an IVC diameter &gt; 30 mm. Patients contraindicated for procedures under fluoroscopy. Patients with demonstrated hypersensitivity to one or more of the components of the OptEase™ filter</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>